Borghi, Claudio http://orcid.org/0000-0001-8039-8781
Fogacci, Federica
Agnoletti, Davide
Cicero, Arrigo F. G.
Article History
Received: 19 January 2022
Accepted: 11 February 2022
First Online: 25 March 2022
Change Date: 19 July 2022
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: Open access funding provided by Alma Mater Studiorum - Università di Bologna within the CRUI-CARE Agreement.
: Claudio Borghi has served as a consultant for Servier, Menarini Corporate, Novartis Pharma, Novo Nordisk, Astra Zeneca, Alfasigma. Federica Fogacci, Arrigo F.G.Cicero and Davide Agnoletti have no conflicts of interest.